Valeant Pharmaceuticals reported $564M in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US USD 9.3B 197M
Ani Pharmaceuticals ANIP:US USD 48.23M 8.05M
Aurora Cannabis Inc ACB:CN CAD 258.71M 110.57M
Biogen BIIB:US USD 3.42B 256.3M
Bristol Myers Squibb BMY:US USD 9.12B 1.39B
Canopy Growth Corp WEED:CN CAD 73.15M 245.28M
Catalent CTLT:US USD 442M 161M
Corcept Therapeutics CORT:US USD 66.33M 16.09M
Danaher DHR:US USD 6B 845M
Drreddys Laboratories RDY:US INR 631M 28M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Gilead Sciences GILD:US USD 7.63B 2.93B
Horizon Pharma HZNP:US USD 2.35B 222.31M
Jazz Pharmaceuticals JAZZ:US USD 517.46M 34.79M
Lannett LCI:US USD 55.85M 22.07M
Nektar Therapeutics NKTR:US USD 88.23M 17.53M
Pacira Pharmaceuticals PCRX:US USD 104.14M 5.28M
Perrigo Ordinary Shares PRGO:US USD 600.7M 132M
Phibro Animal Health PAHC:US USD 68.42M 7.86M
Prestige Brands PBH:US USD 86.36M 43.92M
Revance Therapeutics RVNC:US USD 108.96M 4.47M
Supernus Pharmaceuticals SUPN:US USD 93.12M 18.37M
Valeant Pharmaceuticals VRX:CN USD 564M 78M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B
Zoetis ZTS:US USD 3.58B 1.07B